Résultats de la recherche - 5 results
Inhibition of MALT1 decreases neuroinflammation and pathogenicity of virulent rabies virus in mice.
Steven Van Gucht; Beyaert, R Source: J Virol (2018) Abstract: Rabies virus is a neurovirulent RNA virus, which causes about 59000 human deaths each year. Treatment for rabies does not exist due to ...
MALT1 controls attenuated rabies virus by inducing early inflammation and T cell activation in the brain.
impact of MALT1 on virus infection in the central nervous system. Here, we studied infection with an attenuated rabies virus (ERA) and observed increased susceptibility with ERA in MALT1-/- mice. Indeed, ...
Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG(®)): a global review.
Abstract: RABORAL V- RG (®) is an oral rabies vaccine bait that contains an attenuated (“modified-live”) recombinant vaccinia virus vector vaccine expressing the rabies virus glycoprotein gene (V- RG). ...
Impact of caspase-1/11,-3,-7, or IL-1/IL-18 deficiency on rabies virus-induced macrophage cell death and onset of disease.
Cell Death Discov, Volume 3, p.17012 (2017) Abstract: Rabies virus is a highly neurovirulent RNA virus, which causes about 59000 deaths in humans each year. Previously, we described macrophage ...
Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection.
Rabies Vaccines Rabies virus Single-Domain Antibodies Vaccination Viral Load Abstract: Post-exposure prophylaxis (PEP) against rabies infection consists of a combination of passive immunisation with ...